275 top medical experts on Acute Intermittent Porphyria across 43 countries and 15 U.S. states, including 91 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Acute Intermittent Porphyria: An autosomal dominant porphyria that is due to a deficiency of hydroxymethylbilane synthase in the liver, the third enzyme in the 8-enzyme biosynthetic pathway of heme. Clinical features are recurrent and life-threatening neurologic disturbances, abdominal pain, and elevated level of aminolevulinic acid and porphobilinogen in the urine.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hepatic Porphyrias (226).
  4. Clinical Trials ClinicalTrials.gov : at least 15 including 3 Active, 9 Completed, 2 Recruiting
  5. Synonyms: Hydroxymethylbilane Synthase Deficiency,  Uroporphyrinogen Synthase Deficiency


  

        

                    


    Computing Expert Listing ...

);